Hemp-derived, infused & functional beverage manufacturing

Cannabis driving research · Testing technology

Can a saliva test tell if you're high?

A roadside THC test can detect a drug in someone's saliva. It cannot, by itself, tell an officer how impaired that person is.

So what does the swab actually show? How accurate are the devices? And what happens if the THC came from a drink rather than a joint? Here's what the research says, plus the questions it hasn't answered yet.

Research reviewed Published and maintained by Next Level Leaf

Reading a roadside THC resultConcept illustration
ORAL FLUID SCREEN
THC detected above this device's cutoffPossible
Proof of driving impairment

A chemical result is not a measurement of attention, coordination, or reaction time.

Illustration only. Not a real test result or device interface.

The short answer

It detects THC. It doesn't measure the high.

Most roadside saliva devices give a positive or negative result at a specified cutoff. A positive screen may support an investigation, but it does not establish the amount someone consumed, the exact time they consumed it, or their ability to drive safely.

That distinction matters in both directions: a person can have detectable THC without demonstrated impairment, and a negative screen does not guarantee they are safe to drive. Oral-fluid and blood evidence review ↗

01 / What the result means

Six things people often lump together

When someone says a test can tell whether a driver is “high,” they're combining several different questions. Toxicologists don't treat those questions as interchangeable, and neither should we.

THC present

The sample contains THC, or a substance that triggers the assay, at or above its reporting threshold.

Recent use

Use may have occurred relatively recently. The test cannot give an exact time since consumption.

THC concentration

A measured amount in a particular specimen. Most roadside screens do not display a precise concentration.

Feeling high

A person's subjective experience. It is not something an immunoassay can measure.

Functional impairment

Changes in attention, tracking, reaction time, or other abilities involved in driving.

Legal DUI

Whether the evidence meets a jurisdiction's definition of an offense. That may involve impairment, a prohibited concentration, or a presence rule.

A laboratory can do an excellent job identifying a chemical and still tell us little about someone's performance behind the wheel. That's not a criticism of the laboratory. It's a limit on what the measurement is designed to answer. 2024 individual-participant analysis ↗

02 / The method

What happens when an officer uses a saliva test?

The exact procedure varies, but the basic technology is fairly straightforward. A collector gathers oral fluid with a swab. The sample goes into a disposable test or a reader that checks for specified drugs, usually through an antibody-based assay.

  1. 01

    Collect the sample

    A swab or collection pad gathers saliva. Some systems show when enough fluid has been collected. Dry mouth or an inadequate sample can complicate this step.

  2. 02

    Screen for selected drugs

    A test cartridge or electronic reader looks for THC and often other drug classes. Most roadside devices report positive, negative, or invalid, not a numeric THC concentration.

  3. 03

    Compare with the cutoff

    Each assay has a threshold, typically expressed in nanograms per milliliter (ng/mL). Different models, cartridges, and studies use different cutoffs.

  4. 04

    Decide whether more evidence is needed

    Where authorized, the result may help guide further investigation. That can include officer observations, a drug recognition evaluation, and collection of blood or separate oral fluid for a forensic laboratory.

One small unit, one big distinction. A cutoff of 25 ng/mL in saliva is not equivalent to 25 ng/mL in blood. It's also not a THC dose in milligrams, a clock, or a measure of impairment.

03 / The science

How accurate are roadside THC saliva tests?

Before asking for an accuracy percentage, ask: accurate at what? Detecting THC above a cutoff is different from predicting a blood result. Both are different from measuring driving impairment.

Alabama program evaluation · 2023

Strong performance in a defined testing program

Researchers evaluated SoToxa, DrugTest 5000, and Randox MultiSTAT against laboratory oral-fluid results. The three devices met the study's fit-for-purpose criteria for most targets, although some non-THC drug categories performed less well.

That is device detection performance in selected samples, not a score for detecting impaired drivers.

Read the five-year evaluation ↗
Controlled oral-oil study · 2024

A very different result after a 10 mg oral dose

Twenty adults received an oil containing 10 mg THC and 200 mg CBD or placebo. At 30 minutes, reported THC detection sensitivities were 25% for DrugWipe 5S and 50% for DrugTest 5000 under the study's reference definitions.

This was a specific oral oil, population, and device configuration. It does not predict the result of a 10 mg seltzer.

Read the controlled study ↗

Why those results can both be true

The studies involved different people, routes of use, drug concentrations, test configurations, and comparison standards. A device's accuracy cannot be reduced to a brand-wide percentage without saying exactly what was tested.

A 2022 systematic review of more than 18,000 paired oral-fluid and blood observations found useful agreement for whether THC was present in both specimens. It found weaker performance when saliva was used to infer whether blood exceeded a specified legal concentration. Neither outcome establishes impairment. Systematic review ↗

04 / The beverage question

What if the THC came from a drink?

Imagine someone finishes a THC seltzer and is later asked to take a mouth swab. Could that drink affect the result? Yes, it could. But the odds of a positive screen depend on more than the number printed on the can.

THC in a beverage touches the inside of the mouth before it's absorbed. That creates a question researchers call oral contamination: the swab may detect THC left locally in the mouth rather than simply reflecting THC circulating in the blood.

We have good reasons to study this effect. What we don't yet have is a validated, universal prediction for a commercial 2.5 mg, 5 mg, or 10 mg THC seltzer on every roadside device. Controlled edible study ↗

2.5 mgLimited direct roadside evidence

Don't infer a negative screen just because the labeled dose is low.

5 mgNo universal positivity estimate

A positive is possible, but a dependable probability for a 5 mg seltzer hasn't been established here.

10 mgRelated oral studies exist

Brownie and THC/CBD oil research helps explain the mechanism, not the result for every drink.

Why a brownie isn't a seltzer

In a controlled study, researchers gave 18 adults brownies containing 10, 25, or 50 mg THC. Oral-fluid THC tended to peak immediately after eating, while subjective and performance effects often peaked later. That gap is one reason a swab isn't an impairment meter. But a chewed brownie, swallowed capsule, oil, and slowly sipped drink do not contact the mouth in the same way. Vandrey and colleagues, 2017 ↗

Can the swab tell hemp THC from marijuana THC?

Not from a standard delta-9 THC screening channel. Delta-9 THC is the same molecule regardless of the product's botanical or commercial origin. A positive result does not identify where the product was purchased, whether it qualified as hemp under applicable law, or whether the driver was impaired.

What about delta-8, HHC, or CBD?

That depends on the test. A 2026 University of Alabama at Birmingham thesis found cross-reactivity with selected cannabinoid analogs on particular DrugWipe and DrugCheck devices. Those experiments make assay-specific validation important; they do not tell us how often a consumer of a particular drink would screen positive. Read the UAB device evaluation ↗

What we can say responsibly: a lawful purchase doesn't guarantee a negative test, and a positive test doesn't establish impairment. THC products can impair driving, so the practical safety advice is not to drive while affected.

05 / Devices

How the major testing systems compare

You'll see the same names repeatedly in police programs and scientific papers. The important details are the exact device, its test cartridge, the cutoff, and whether the result is only a screen.

Examples from published evaluations and manufacturers. Cutoffs depend on configuration and are not impairment thresholds.
SystemFormatTHC cutoff exampleWhat to know
Abbott SoToxaHandheld electronic reader25 ng/mLUsed in U.S. police programs. Screens for drug presence; confirmation is a separate step.
Dräger DrugTest 5000Transportable electronic analyzer5, 10, or 25 ng/mLDifferent cartridge configurations. A 25 ng/mL configuration was used in the 2024 oral-oil study.
Dräger DrugCheck 3000Single-use visual test15 or 25 ng/mL modesNo reader required; interpret according to the exact product instructions.
Securetec DrugWipe 5S/6SDisposable visual test10 ng/mL in the cited 5S studyModel and market versions differ. Do not assume one cutoff or cross-reactivity profile.
Randox Evidence MultiSTATBenchtop biochip analyzer5 ng/mL in Alabama's studyScreening instrument, not LC-MS/MS confirmation and not a handheld roadside swab.

Cutoff references: Alabama comparative evaluation, oral-oil study, and the respective manufacturer specifications. Published evaluations may use older product configurations.

ScreeningA preliminary indication of a drug at the test's decision threshold.
ConfirmationA separate forensic analysis, commonly LC-MS/MS, intended to identify specific chemicals reliably.

06 / The investigation

What happens after a positive screen?

There isn't one national procedure. Depending on the law and the circumstances, an officer may consider driving behavior, observations, standardized field sobriety tests, and an evaluation by a Drug Recognition Expert (DRE). An evidentiary specimen may then be collected and analyzed by a laboratory.

01Driving and roadside observationsWhy the investigation began
02Possible oral-fluid screenPreliminary chemical result
03Additional evidence and evaluationBehavior, training-based assessment, and legal process
04Forensic specimen, when authorizedBlood or separate laboratory oral fluid
05Legal interpretationOffense elements differ by jurisdiction

This is an explanatory sequence, not a universal police protocol. Evaluations and sample collection may occur in a different order, and a roadside device may not be used at all.

How do officers assess cannabis impairment?

A saliva swab is only one possible part of a drug-impaired-driving investigation. Officers may start with the driving itself: unsafe lane changes, delayed responses, or other observations. They can also ask a driver to perform coordination and divided-attention tasks, such as walking a straight line or standing on one leg. Those are commonly called field sobriety tests.

There is an important catch. These tests were developed largely for alcohol investigations. They can provide useful observations, but they are not a reliable stand-alone way to identify THC impairment. Horizontal gaze nystagmus, the involuntary eye movement checked during an alcohol investigation, is not considered a characteristic sign of cannabis use alone.

A trained Drug Recognition Expert (DRE) can perform a more detailed, standardized 12-step evaluation. It may involve eye examinations, balance and coordination assessments, vital signs, and a review of other evidence. The evaluation is broader than a THC swab, but it is still an assessment that must be interpreted in context, not a direct measurement of THC's effects on driving.

In a 2023 randomized clinical trial of 184 cannabis users, officers classified 81% of participants given THC as impaired on field sobriety tests, but also classified 49.2% of the placebo group that way. The study did not show that field tests are useless. It showed why a test result or officer observation should not be treated as conclusive evidence of cannabis-specific impairment on its own. See also the IACP's DRE protocol and NIJ's discussion of controlled dosing research.

Are roadside swabs mandatory? And what does a legal THC limit mean?

There is no single nationwide answer. The authority to request or require a preliminary saliva sample, the consequences of refusing, and whether the result can be used in court depend on the jurisdiction and the purpose of the test. Some laws use impairment-based offenses, while others define a separate offense or inference using a specified drug concentration in blood. A blood limit is not a saliva-device cutoff, and a legal threshold is not necessarily a scientifically validated measurement of impairment.

For example, Kansas law imposes restrictions on the courtroom use of preliminary oral-fluid results, while Washington law establishes a voluntary roadside framework. Those examples illustrate the differences rather than telling readers what applies to their own traffic stop.

Why confirmation matters

Immunoassays are designed to screen quickly. Laboratory methods such as liquid chromatography with tandem mass spectrometry (LC-MS/MS) can identify specific drugs more reliably. But confirmation answers the chemical question. It does not, on its own, prove that someone was driving while impaired.

Blood, saliva, and urine aren't interchangeable

SpecimenWhat it can help showMain limitation
Oral fluidDrug presence, often relevant to relatively recent exposureMouth residue, collection method, route and cutoff affect interpretation
BloodCirculating parent THC and metabolites near collection timeTHC concentration changes quickly and does not map neatly to impairment
UrinePrior exposure, often through metabolitesEspecially poor for determining impairment at the driving event

Why isn't there a cannabis version of 0.08 BAC?

Alcohol has a much stronger population-level concentration-and-driving-risk evidence base. THC behaves differently: effects vary with inhalation versus ingestion, blood concentrations change quickly, and people with different use histories can respond differently. Legislatures can set THC limits, but those numbers should not be confused with a universally validated personal impairment threshold. Review of oral-fluid variability ↗

Is there one national THC saliva-test rule?

No single federal roadside rule governs every driver or tells every state which THC oral-fluid cutoff proves impairment. State laws and agency procedures differ. NHTSA has studied how states use these tools, including a 2026 case-study report on Alabama, Indiana, Kansas, New York, and Washington. Its interviews were conducted in 2025.

You may also see federal workplace oral-fluid cutoffs of 4 ng/mL for the initial THC test and 2 ng/mL for confirmation. Those numbers come from U.S. DOT workplace drug-testing regulations. They are not national roadside impairment limits. NHTSA state case studies ↗ DOT workplace cutoffs ↗

07 / Court decisions

What have courts actually ruled about roadside THC testing?

A positive swab can become evidence in a real case. But when a judge reviews a THC test, the question isn't always whether the driver was impaired. Courts may be deciding whether a device's result can be shown to a jury, whether a blood sample was collected legally, or whether a particular THC threshold is constitutional.

Here are six documented examples. Only two directly mention a named roadside saliva device. The other rulings help explain how judges interpret THC results, officer observations, and the rules surrounding their use.

People v. Junior Salas (California, 2015–2016)

Kern County Superior Court · Dräger DrugTest 5000 · Trial-court ruling

Screen admitted

After a fatal collision involving evidence of several substances, a Kern County judge permitted results from a Dräger DrugTest 5000 oral-fluid screen to be presented to the jury. The jury later found Salas guilty of vehicular manslaughter while intoxicated.

What the decision means: A judge admitted this particular screen after a scientific-reliability hearing. That is not a statewide appellate ruling, and the verdict does not show that the saliva test, by itself, established cannabis impairment. This was not a THC-only prosecution.

AAA oral-fluid toolkit, court-record appendix ↗ · Manufacturer account of the verdict ↗

State v. Fraser (Washington, 2022)

Washington Supreme Court · Blood THC · Constitutional challenge

Conviction upheld

The court upheld a conviction under Washington's law covering drivers whose whole-blood THC reaches at least 5 ng/mL within two hours after driving. The justices acknowledged the scientific uncertainty of linking a specific THC concentration to impairment, but held the statutory rule was not facially unconstitutional.

What the decision means: A state's legal threshold can be enforceable even though it is not a universal scientific measure of impairment. This was a blood-test case, not a saliva-device ruling.

Read the Washington Supreme Court opinion ↗

Commonwealth v. Gerhardt (Massachusetts, 2017)

Massachusetts Supreme Judicial Court · Roadside assessments

Testimony limited

Officers could describe a driver's balance, coordination, and behavior during roadside assessments. But without appropriate expert qualification, they could not testify that the person was impaired by marijuana or say the person had “passed” or “failed” a cannabis test.

What it means: Observed behavior may be evidence, but the court restricted the conclusion an officer could draw from it. No saliva device was tested in this ruling.

Read the published opinion ↗

City of Seattle v. Pearson (Washington, 2016)

Washington Court of Appeals · Warrantless blood draw

Conviction reversed

The court reversed and sent back a cannabis DUI conviction after finding error in admitting a warrantless blood draw and testimony about a THC threshold that did not exist when the incident occurred.

What it means: How evidence is collected and presented matters, not just what it reports. This ruling concerned blood evidence, not a saliva screen.

Read the Washington appellate opinion ↗

Dupree v. Mississippi Department of Employment Security (Mississippi, 2026)

Mississippi Court of Appeals · Oral swab after reported delta-8 gummy use · Employment case

Benefits denial reversed

A city employee tested positive for THC on an oral swab, reported using over-the-counter delta-8 gummies, and later tested negative on blood and urine tests. The appeals court found the record did not establish misconduct under the employer's policy and reversed the denial of unemployment benefits.

What it means: This is a real example of how an oral-swab result can be challenged in a legal dispute. It was not a driving case, and the court did not determine that the swab was analytically false or rule on any named roadside device.

Read the Mississippi appellate opinion ↗

Hartman v. State (Indiana, 2026)

Indiana Court of Appeals · SoToxa test mentioned · Sentencing appeal

Sentence affirmed

A SoToxa test following a collision screened positive for cannabis and other drugs. Hartman pleaded guilty after admitting alcohol-related intoxication, and the appellate court affirmed his sentence.

What it means: The published account confirms SoToxa appeared in this investigation. The court did not rule on SoToxa's accuracy or admissibility; it reviewed a sentence. The decision is a nonprecedential memorandum opinion under Indiana's rules.

Read the Indiana appellate memorandum ↗

What these cases do not establish: There is no single nationwide court ruling declaring roadside THC saliva tests proof of impairment, or categorically banning them as evidence. Admissibility, the weight of a result, consent and warrants, and the definition of DUI depend on the jurisdiction and the facts. A positive test is not automatically a conviction, but it also cannot be dismissed as legally irrelevant everywhere.

What are defense attorneys saying?

Law firms are also publishing technical critiques. Deandra Grant Law's 2026 discussion examines device reliability, collection records, and the gap between detection and impairment. Dominy Law Firm's Ohio FAQ discusses the evidentiary limits of preliminary saliva screening. These are attorneys' interpretations, not court decisions; the opinions linked above are the better starting point for what a judge actually ruled.

08 / State resources

Where are roadside THC testing programs being used or discussed?

States aren't all doing the same thing. Some have roadside screening programs. Some accept laboratory-tested oral fluid as evidence. Others have completed pilots or are still considering the idea. Here are documented examples, with source links and careful status wording.

Showing 10 researched examples

AlabamaRoadside screening + forensic oral fluidOperating program

Alabama's Department of Forensic Sciences describes two related services: preliminary roadside screening and separate evidentiary laboratory testing of oral-fluid specimens. Its webpage lists several approved screening devices. This is one of the clearest examples of how the two stages differ.

Last source review: Nov. 13, 2026 · Alabama Department of Forensic Sciences ↗

IndianaSoToxa roadside screening programOperating program

Indiana's Criminal Justice Institute says its oral-fluid program began in December 2020. Its published 2025 figures report more than 200 devices distributed in support of approximately 110 law-enforcement agencies. These are drug screens, not direct tests of driving impairment.

Last source review: Nov. 13, 2026 · Indiana Criminal Justice Institute ↗

KansasPreliminary screening under state statuteProgram / statute

Kansas statute 8-1012 allows officers, under specified conditions, to request a preliminary breath or oral-fluid screen. It permits specified investigative uses while restricting admissibility of the preliminary result in proceedings about vehicle operation. The NHTSA case study documents the state's program-development work; it is not a live inventory of every agency.

Last source review: Nov. 13, 2026 · Kansas statute ↗ · NHTSA case study ↗

New YorkEvidentiary laboratory oral-fluid programOperating program

New York State Police launched a statewide evidentiary oral-fluid program in July 2024 after a pilot. This means the laboratory can analyze properly collected oral fluid as an evidentiary specimen in applicable cases. It does not mean a handheld roadside test independently proves impairment.

Last source review: Nov. 13, 2026 · 2026 New York State Police forensic publication ↗

KentuckyAgency-reported rolloutProgram described

Kentucky's Department of Criminal Justice Training published a July 2026 discussion of the state's roadside oral-fluid testing program and how the rollout took place. The available agency summary does not establish a complete device list, thresholds, or courtroom procedures; those remain unverified here.

Last source review: Nov. 13, 2026 · Kentucky agency program discussion ↗

WashingtonVoluntary roadside-testing statuteLegal framework

Washington law explicitly addresses voluntary roadside oral-fluid tests. It requires a warning that results cannot be used against the person in court and that the swab is not a substitute for an evidentiary breath or blood test. Current statewide deployment is not established by the statute itself.

Last source review: Nov. 13, 2026 · RCW 46.61.5062 ↗

Minnesota2024 roadside screening pilotPast pilot

Minnesota conducted a roadside oral-fluid pilot during 2024. That is valuable evidence of a testing approach, but it doesn't establish that the same program is operating statewide in November 2026. Further program-status verification is required before using a stronger label.

Last source review: Nov. 13, 2026 · Minnesota DPS pilot-results announcement ↗

MichiganMulti-phase historical roadside pilotsPast pilots

Michigan tested preliminary oral-fluid procedures in earlier pilot phases, with a framework tied to participating counties and drug-recognition experts. Those historical pilots are not evidence that an identical statewide program is operating today.

Last source review: Nov. 13, 2026 · Michigan statutory pilot provision ↗

North CarolinaProposed data-collection-only pilotProposal

At an October 28, 2026, Public Safety Subcommittee meeting, an NCDHHS official described a possible data-only oral-fluid pilot involving the State Highway Patrol. The minutes say the concept was not finalized and that proposed results would not be used in court. They do not settle device selection, THC cutoffs, consent rules, or every potential investigative use.

Last source review: Nov. 13, 2026 · October 28 NCDHHS minutes ↗

ColoradoExample of a blood THC legal ruleLaw, not swab program

Colorado's whole-blood THC permissible-inference provision is a useful example of why a legal blood threshold cannot be substituted for a roadside saliva test cutoff. We have not classified Colorado's current oral-fluid deployment in this research.

Last source review: Nov. 13, 2026 · Colorado Revised Statutes § 42-4-1301(6)(a)(IV) ↗. The cited blood rule is distinct from any roadside saliva-program status.

These are selected examples, not a ranking or a claim that other states have no programs. Each summary identifies the type of evidence and its last review date. Program implementation and court rules can change.

09 / What's next

Will a THC breathalyzer or eye test replace the swab?

Researchers and companies are testing several possibilities. But a device that detects THC, even in breath, still has to answer a separate question before anyone can call it an impairment test: does its result reliably track driving-related performance?

THC in breath

Researchers are studying how to collect and measure cannabinoids in exhaled aerosols and vapor. NIST published technical measurement work in 2026. Detecting THC in breath is not yet the same as measuring impairment.

NIST research ↗
Research / development

Eye tracking and pupil response

Some developers are testing whether changes in eye movements or pupil responses can help identify recent drug effects. Independent, real-world validation is essential before such claims are treated as reliable measures of driving impairment.

Research / pilots

Cognitive and reaction-time tasks

These approaches test performance more directly, but outcomes can be influenced by fatigue, illness, other drugs, and individual differences. They still need defensible roadside procedures and reference standards.

Research / limited use

Wearables and physiological signals

These systems aim to detect patterns in movement or physiology. For now, the evidence does not establish a general-purpose, roadside THC impairment standard.

Experimental

The direction worth watching is better evidence of actual impairment, not simply a faster way to report that THC is present.

10 / Common questions

Questions readers usually have

Can a saliva test tell if I'm high right now?

No. It may detect THC at or above a device's cutoff, but that is not a direct test of attention, coordination, or driving impairment.

Can one 5 mg THC drink cause a positive roadside test?

It is possible, but there is no universal probability or detection window for a particular 5 mg drink. The device, timing, route, and individual all matter.

How long does THC stay in saliva?

There is no dependable single number. Findings vary with dose, route of use, use frequency, collection procedure, and test cutoff. A laboratory detection period is not a safe-driving countdown.

Can a test tell hemp-derived THC from marijuana-derived THC?

Not from a standard delta-9 THC screening result. The chemical target does not reveal which product the person consumed or where it was purchased.

Does a positive roadside swab automatically mean a DUI?

No. The legal significance depends on the jurisdiction, the applicable offense, and the remaining evidence. Some programs treat the swab as preliminary only, while some jurisdictions also permit laboratory oral-fluid evidence.

Is a laboratory-confirmed THC result proof of impairment?

No. Laboratory confirmation can establish a more reliable chemical finding. Whether a person was legally impaired requires an analysis of the governing law and other evidence.

Is a negative saliva test proof that it's safe to drive?

No. A screen can be negative even when someone is affected by THC or another substance. Testing cutoffs are not individual safety thresholds.

How do police check for cannabis impairment besides a saliva swab?

Officers may consider driving observations, divided-attention and coordination tasks, and a Drug Recognition Expert evaluation. Field tests are not a definitive cannabis-specific impairment measure, and a chemical screen does not measure driving performance.

Can I refuse a roadside THC saliva test?

The answer depends on the jurisdiction and whether the test is preliminary, voluntary, or part of an evidentiary collection process. Consent and refusal rules can differ substantially, so a general national answer would be misleading.

Have courts admitted roadside THC saliva tests as evidence?

Yes, in at least one reported California trial-court case, a judge allowed Dräger DrugTest 5000 results to be heard by a jury. That ruling was limited to the particular case, not a nationwide approval of roadside devices. Other states have different evidentiary rules.

Can someone be convicted based only on a positive THC test?

That depends on what was tested and the law involved. Some states have blood-THC per se rules; other cases require proof of impairment. A preliminary oral-fluid screen and a laboratory-confirmed blood THC concentration are different kinds of evidence. A saliva result alone does not scientifically measure impairment.

Does a state pilot mean saliva testing is mandatory there?

Not necessarily. A pilot, statutory authorization, agency deployment, and evidentiary use are separate facts. Check the program's official documents rather than relying on a generic state list.

11 / Sources and methodology

Where this information comes from

We prioritize government records, forensic laboratory documentation, and peer-reviewed studies. Manufacturer information is useful for understanding a particular device, but we don't treat marketing claims as independent proof of performance.

  1. NHTSA: Oral Fluid Testing Program Case Studies (2026). Five state implementation examples based on 2025 interviews.
  2. Alabama Department of Forensic Sciences: Oral Fluid Drug Testing Program. Current agency methods and device list.
  3. Harper and colleagues: Alabama five-year program evaluation. Journal of Analytical Toxicology, 2023.
  4. Oral fluid and blood THC correlation: Systematic review, 2022.
  5. Marcotte and colleagues: Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis. JAMA Psychiatry, 2023.
  6. Macdonald and Zhao: Oral-fluid THC individual-participant meta-analysis, 2024.
  7. Vandrey and colleagues: Controlled cannabis brownie study, 2017.
  8. Point-of-collection devices following THC/CBD oral oil, 2024.
  9. Jenkins: Novel Oral Fluid Drug Screening Device Evaluation. UAB master's thesis, 2026.
  10. New York State Police forensic oral-fluid program, 2026.
  11. NCDHHS Public Safety Subcommittee: October 28, 2026 minutes.
  12. U.S. DOT 49 CFR § 40.91: Workplace oral-fluid cutoffs. Included to distinguish workplace limits from roadside testing.
  13. NIST: Measurements for cannabis breathalyzer development, 2026.
  14. AAA: Use of Oral Fluid to Detect Drugged Drivers, including People v. Salas appendix, 2022. Trial-court register excerpts; distinct from a binding appellate opinion.
  15. State v. Fraser, Washington Supreme Court, 2022. Blood-THC per se law upheld.
  16. Commonwealth v. Gerhardt, Massachusetts Supreme Judicial Court, 2017. Roadside-assessment testimony.
  17. City of Seattle v. Pearson, Washington Court of Appeals, 2016. Warrantless blood evidence and inapplicable legal threshold.
  18. Dupree v. Mississippi Department of Employment Security, Mississippi Court of Appeals, 2026. Non-driving oral-swab employment case.
  19. Hartman v. State, Indiana Court of Appeals, 2026. Nonprecedential sentencing appeal referencing SoToxa.

How we maintain this page

We distinguish preliminary roadside screens from laboratory confirmation, operating programs from pilots, and scientifically validated findings from manufacturer claims. Sources were reviewed through November 13, 2026. A state summary is not a complete legal audit.

Next Level Leaf works in the infused-beverage industry. We include that commercial perspective openly, but testing and impairment claims are based on outside scientific and government evidence.

This material is educational, not individual medical or legal advice. Cannabis and THC can impair driving. Do not drive while impaired.

Keep exploring

Researching hemp beverages or planning a product?

For the broader rules affecting hemp-derived beverages, see our federal tracker. If you're building a beverage brand, our manufacturing resources explain the production side.

Google Preferred Sources

Want to see more Next Level Leaf research on Google?

If you find our hemp policy, state-law resources, and beverage manufacturing research useful, choose Next Level Leaf as one of your Preferred Sources on Google. Google controls how and where selected sources are highlighted.

Add Next Level Leaf to Preferred Sources

This opens Google's source-preference experience. Your selection remains under your control.